Sage Rhino Capital LLC Amgen Inc Transaction History

Sage Rhino Capital LLC

  • $407 Million
  • Q2 2024

A detailed history of Sage Rhino Capital LLC transactions in Amgen Inc stock. As of the latest transaction made, Sage Rhino Capital LLC holds 2,453 shares of AMGN stock, worth $783,929. This represents 0.19% of its overall portfolio holdings.

Number of Shares
2,453
Previous 2,504 2.04%
Holding current value
$783,929
Previous $711,000 7.74%
% of portfolio
0.19%
Previous 0.17%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024
SELL
$262.75 - $319.31 $13,400 - $16,284
-51 Reduced 2.04%
2,453 $766,000
Q1 2024

Apr 26, 2024
BUY
$268.87 - $324.56 $9,141 - $11,035
34 Added 1.38%
2,504 $711,000
Q4 2023

Feb 05, 2024
SELL
$255.7 - $288.46 $767 - $865
-3 Reduced 0.12%
2,470 $711,000
Q3 2023

Oct 26, 2023
BUY
$218.65 - $271.46 $874 - $1,085
4 Added 0.16%
2,473 $664,000
Q2 2023

Jul 31, 2023
SELL
$214.27 - $253.37 $16,927 - $20,016
-79 Reduced 3.1%
2,469 $548,000
Q1 2023

Apr 20, 2023
SELL
$225.79 - $275.2 $326,266 - $397,664
-1,445 Reduced 36.19%
2,548 $615,000
Q4 2022

Jan 31, 2023
BUY
$229.03 - $291.01 $341,941 - $434,477
1,493 Added 59.72%
3,993 $1.05 Million
Q3 2022

Oct 24, 2022
SELL
$224.46 - $253.15 $6,958 - $7,847
-31 Reduced 1.22%
2,500 $564,000
Q2 2022

Jul 28, 2022
SELL
$230.71 - $256.74 $1,384 - $1,540
-6 Reduced 0.24%
2,531 $616,000
Q1 2022

Apr 27, 2022
BUY
$219.27 - $242.57 $1,754 - $1,940
8 Added 0.32%
2,537 $613,000
Q4 2021

Feb 04, 2022
BUY
$198.88 - $227.6 $8,154 - $9,331
41 Added 1.65%
2,529 $569,000
Q3 2021

Oct 18, 2021
BUY
$212.27 - $248.7 $4,882 - $5,720
23 Added 0.93%
2,488 $529,000
Q2 2021

Jul 27, 2021
BUY
$233.58 - $259.14 $3,737 - $4,146
16 Added 0.65%
2,465 $601,000
Q1 2021

May 04, 2021
BUY
$221.91 - $258.6 $28,182 - $32,842
127 Added 5.47%
2,449 $609,000
Q3 2020

Nov 05, 2020
SELL
$234.65 - $260.95 $469 - $521
-2 Reduced 0.09%
2,322 $590,000
Q2 2020

Jul 30, 2020
BUY
$197.81 - $242.74 $19,187 - $23,545
97 Added 4.36%
2,324 $548,000
Q1 2020

Apr 29, 2020
SELL
$182.24 - $241.7 $4,191 - $5,559
-23 Reduced 1.02%
2,227 $451,000
Q4 2019

Jan 31, 2020
SELL
$189.21 - $243.2 $7,000 - $8,998
-37 Reduced 1.62%
2,250 $536,000
Q3 2019

Oct 25, 2019
BUY
$174.11 - $208.62 $13,232 - $15,855
76 Added 3.44%
2,287 $443,000
Q2 2019

Aug 20, 2019
SELL
$166.7 - $195.41 $19,837 - $23,253
-119 Reduced 5.11%
2,211 $407,000
Q1 2019

Apr 18, 2019
BUY
$180.87 - $203.88 $421,427 - $475,040
2,330 New
2,330 $443,000

Others Institutions Holding AMGN

# of Institutions
3,056
Shares Held
409M
Call Options Held
7.19M
Put Options Held
6.26M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Sage Rhino Capital LLC Portfolio

Follow Sage Rhino Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Rhino Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Rhino Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email